Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

Abstract

Serum AGE concentrations may be associated with long term poor glycaemic control and reflect the severity of coronary arteriosclerosis in type 2 diabetic patients.